Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The temporal relation of hepatitis C virus (HCV) infection to the development of type 2 diabetes remains unknown. The authors followed 4,958 persons aged > or =40 years without diabetes (3,486 seronegative, 812 anti-HCV+, 116 with hepatitis B virus/HCV coinfection, and 544 hepatitis B surface antigen (HBsAg)+) from a community-wide cohort in southern Taiwan for 7 years (1997-2003) to study the risk of diabetes associated with HCV infection. A total of 474 participants developed diabetes. The 7-year cumulative incidence was 7.5% for HBsAg+, 8.6% for seronegative, 14.3% for anti-HCV+, and 14.7% for coinfected participants. Compared with HCV- persons, HCV+ persons had a higher cumulative incidence of diabetes (log-rank test, p < 0.0001). A multivariate Cox proportional hazards model showed that anti-HCV+ (hazard ratio = 1.7, 95% confidence interval: 1.3, 2.1), coinfection (hazard ratio = 1.7), overweight, obesity, and increasing age were significantly associated with diabetes (p < 0.05). Gender, educational level, HBsAg+ status, alcohol consumption, and smoking were not significant. After stratification by age and body mass index, the risk ratio for diabetes in anti-HCV+ participants increased when age decreased and body mass index levels increased (p < 0.001). Results show that HCV infection is an independent predictor of diabetes, especially for anti-HCV+ persons who are younger or have a higher body mass index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Associations have been made between certain pathogens and T2D risk: herpes simplex virus type 1 and hepatitis C virus are risk factors for T2D, although it is not clear how this can be mechanistically explained.86,87”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [87]
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 3×
“Hepatitis C virus (HCV) infection and type 2 diabetes are two worldwide, major public health problems with increasing complication and mortality rates (1, 2).”
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477 · cited 1×
“Hepatitis B virus (HBV) and HBV/HCV coinfections are well-known etiologic factors related to hepatocellular carcinoma (21).”
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230 · cited 1×
“Second, the comorbidity of diabetes and HCV infection at a younger age might exacerbate liver problems because these two conditions greatly increase the progression of hepatic fibrosis (26) and the risk of hepatocellular carcinoma (27).”
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073 · cited 1×
“First, HCV-RNA was not tested to elucidate the relation between actual viral status and past infection, and 15–26 percent of the anti-HCVþ participants were HCV-RNA and indicated past infection (2, 37).”
Screening for type 2 diabetes.
Engelgau, M. M., Narayan, K. M., & Herman, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1563 · Cited by 1,027
Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763 · cited 3×
“Insulin resistance was recently confirmed in an experiment using a transgenic mouse model with an HCV core gene (34).”
InfluentialInsulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718 · cited 1×
“Second, the comorbidity of diabetes and HCV infection at a younger age might exacerbate liver problems because these two conditions greatly increase the progression of hepatic fibrosis (26) and the risk of hepatocellular carcinoma (27).”
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Montori, V. M., Basu, A., Erwin, P. J., Velosa, J. A., Gabriel, S. E., & Kudva, Y. C. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.583 · Cited by 528 · cited 1×
“However, most of the patients in these studies were old, had advanced liver diseases, and had received immunosuppressive therapy, all of which are highly associated with diabetes (18).”
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
Lonardo, A., Adinolfi, L. E., Loria, P., Carulli, N., Ruggiero, G., & Day, C. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.020 · Cited by 477 · cited 2×
“Overweight and obesity are major causes of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes (28, 30).”
Hepatitis C Virus Infection and Incident Type 2 Diabetes
Mehta, S. H., Brancati, F. L., Strathdee, S. A., Pankow, J. S., Netski, D., Coresh, J., Szklo, M., & Thomas, D. L. (2003) · Hepatology · doi:10.1053/jhep.2003.50291 · Cited by 404 · cited 1×
“One casecohort study (19) did suggest that HCV infection increased the risk of diabetes but did not include enough cases to draw”
Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B. D., & Alexander, G. J. M. (1999) · Hepatology · doi:10.1002/hep.510300416 · Cited by 396 · cited 3×
“All of these studies are crosssectional, and some had small populations or included participants with advanced liver diseases (6, 9, 11) such as cirrhosis and hepatoma, which cause glucose intolerance and insulin resistance (11, 14).”
Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.012 · Cited by 340
Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus Infection
Knobler, H., Schihmanter, R., Zifroni, A., Fenakel, G., & Schattner, A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.355 · Cited by 292
Baid, S., Cosimi, A. B., Lin Farrell, M., Schoenfeld, D. A., Feng, S., Chung, R. T., Tolkoff-Rubin, N., & Pascual, M. (2001) · Transplantation · doi:10.1097/00007890-200109270-00015 · Cited by 284
High Prevalence of Hepatitis C Virus Infection in Diabetic Patients
Simó, R., Hernández, C., Genescà, J., Jardí, R., & Mesa, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.998 · Cited by 275
Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis†
Petrides, A. S., Vogt, C., Schulze-Berge, D., Matthews, D., & Strohmeyer, G. (1994) · Hepatology · doi:10.1002/hep.1840190312 · Cited by 262 · cited 1×
“All of these studies are crosssectional, and some had small populations or included participants with advanced liver diseases (6, 9, 11) such as cirrhosis and hepatoma, which cause glucose intolerance and insulin resistance (11, 14).”
Zein, N. N., Abdulkarim, A. S., Wiesner, R. H., Egan, K. S., & Persing, D. H. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80065-3 · Cited by 257 · cited 1×
“All of these studies are crosssectional, and some had small populations or included participants with advanced liver diseases (6, 9, 11) such as cirrhosis and hepatoma, which cause glucose intolerance and insulin resistance (11, 14).”
The injection century: massive unsterile injections and the emergence of human pathogens
Drucker, E., Alcabes, P. G., & Marx, P. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06967-7 · Cited by 218 · cited 1×
“This finding is important for public health and clinical practice because the prevalence of HCV infection is endemic in some developing countries or, in particular, high-risk groups in developed countries because of unsafe injections and intravenous drug use (2, 20, 31).”
(2015) · Diagnostic Pathology: Infectious Diseases · doi:10.1016/b978-0-323-37677-8.50024-3 · Cited by 172
Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation
Bigam, D. L., Pennington, J. J., Carpentier, A. C., Wanless, I. R., Hemming, A. W., Croxford, R., Greig, P. D., Lilly, L., Heathcote, J., Levy, G. A., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8270 · Cited by 155
Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection.
FRASER, G. M., Harman, I., Meller, N., Niv, Y., & Porath, A. (1996) · PubMed · Cited by 142
HCV and diabetes mellitus: evidence for a negative association
Mangia, A., Schiavone, G., Lezzi, G., Marmo, R., Bruno, F., Villani, M. R., Cascavilla, I., Fantasia, L., & Andriulli, A. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00688.x · Cited by 131 · cited 1×
“Although most studies (3–11) report that HCV infection is significantly associated with diabetes, some either find no significant association (12) or reject the hypothesis that HCV infection triggers diabetes (13).”
Hepatitis C Virus Infection and Human Pancreatic β-Cell Dysfunction
Masini, M., Campani, D., Boggi, U., Menicagli, M., Funel, N., Pollera, M., Lupi, R., Guerra, S. D., Bugliani, M., Torri, S., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.940 · Cited by 125 · cited 1×
“One other study (36) showed that HCV is present in human pancreatic b cells and has a direct cytopathic effect at the islet-cell level, accompanied by morphologic changes and functional defects in insulin secretion.”
Insulin resistance and insulin secretion in chronic hepatitis C virus infection
Narita, R., Abe, S., Kihara, Y., Akiyama, T., Tabaru, A., & Otsuki, M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.020 · Cited by 102
Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg259 · Cited by 92 · cited 3×
“However, this cohort was collected from a community-wide hepatitis screening, and, using abdominal sonography, we had conducted a cross-sectional study in which liver disease severity in most of the HBVþ and HCVþ participants was distributed normally (3).”
Self-citationPost-liver transplantation diabetes mellitus: An association with hepatitis C
AlDosary, A. A., Ramji, A. S., Elliott, T. G., Sirrs, S. M., Thompson, D. M., Erb, S. R., Steinbrecher, U. P., & Yoshida, E. M. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.31745 · Cited by 82
Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes
Fukui, M., Kitagawa, Y., Nakamura, N., & Yoshikawa, T. (2003) · JAMA · doi:10.1001/jama.289.10.1245-b · Cited by 81
Low prevalence of hepatitis C virus infection in Greek diabetic patients
Sotiropoulos, A., PEPPAS, T., Skliros, E. A., Apostolou, O., Kotsini, V., & Pappas, S. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00009.x · Cited by 51 · cited 1×
“Although most studies (3–11) report that HCV infection is significantly associated with diabetes, some either find no significant association (12) or reject the hypothesis that HCV infection triggers diabetes (13).”
Association of Chronic Hepatitis C Virus Infection and Diabetes Mellitus in Korean Patients
Ryu, J. K., Lee, S. B., Hong, S. J., & Lee, S. K. (2001) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2001.16.1.18 · Cited by 50 · cited 2×
“This finding is consistent with past studies (3–11, 15–17, 19) showing that HCV infection, but not HBV infection (3, 8, 10, 11), is highly associated with diabetes.”
Hepatitis C: A metabolic liver disease
Weinman, S. A., & Belalcazar, L. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.01.001 · Cited by 40
Liu, C., Chen, P., & Chen, D. (2004) · Hepatology · doi:10.1002/hep.20298 · Cited by 15 · cited 1×
“The number of coinfections is substantial, especially in areas where the two viruses are endemic and for those persons with a high risk of unsafe medical injections (20, 22), but, to our knowledge, the relation between coinfection and diabetes has not been reported.”
Cited by
Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis
Agardh, E., Allebeck, P., Hallqvist, J., Moradi, T., & Sidorchuk, A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr029 · Cited by 1,014
Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00316-2 · Cited by 551
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
White, D. L., Ratziu, V., & El-Serag, H. B. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.006 · Cited by 451
“Although the preponderance of current evidence suggests hepatitis C infection may convey additional DM risk beyond that conveyed by BMI, additional prospective studies are therefore needed to sort out the important aspect of the interaction between HCV infection and other risk factors for diabetes including current an…”
BackgroundMethodResultInfluentialReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.035 · Cited by 361
Metadata
- Authors
- Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P.
- Affiliations
- National Yang Ming University (TW)
- National Cheng Kung University (TW)
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-07
- Volume
- 166
- Issue
- 2
- Pages
- 196-203
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2130453232
- Cited by
- 166
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 15 · 2016: 13 · 2015: 15 · 2014: 6 · 2013: 6 · 2012: 11
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hepatitis C, type 2 diabetes, diabetes risk factors, hepatitis B surface antigen, obesity, body mass index, age, cumulative incidence, community-based cohort
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Hepatitis B, Hepatitis B Surface Antigens, Hepatitis C, Humans, Longitudinal Studies, Male, Middle Aged, Obesity, Risk, Taiwan, Incidence, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.